Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_assertion type Assertion NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_head.
- NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_assertion description "[Patients with HER2 scores >or= 2+ had a significantly higher chance of dying from prostate cancer than those with HER2 scores of 0 (P = 0.004) and 1+ (P = 0.034).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_provenance.
- NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_assertion evidence source_evidence_literature NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_provenance.
- NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_assertion SIO_000772 18645672 NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_provenance.
- NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_assertion wasDerivedFrom befree-20140225 NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_provenance.
- NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_assertion wasGeneratedBy ECO_0000203 NP436175.RAEaigmmZx4rFXHZe0vpA-ok96qDbygbLks2_P0_sWykc130_provenance.